cabozantinib,atezolizumab
exelixis,roche
['urothelial carcinoma', 'atezolizumab', 'bladder', 'cabozantinib', 'urothelial']
nice talk from at #asco22 during the genitourinary cancer kidney and bladder session, concluding that cabozantinib plus atezolizumab demonstrated clinical activity in inop. locally-advanced/metastatic urothelial carcinoma
Independent and international experts in GenitoUrinary (GU) oncology. Part of https://t.co/QAbKORwRcf